entacapone 200 MG Oral Tablet

INDICATIONS AND USAGE Entacapone tablets USP are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose "wearing-off" in patients with Parkinson's disease (see CLINICAL PHARMACOLOGY, Clinical Studies ). Entacapone's effectiveness has not been systematically evaluated in patients with Parkinson's disease who do not experience end-of-dose "wearing-off".

lannett company, inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] off label use` `[3] drug ineffective` `[4] pain` `[5] toxicity to various agents` `[6] nausea` `[7] headache` `[8] arthralgia` `[9] dyspnoea` `[10] pyrexia`

4 years ago

OVAL ORANGE S51

HOW SUPPLIED

ENTACAPONE tablets USP are supplied as 200 mg film-coated tablets for oral administration. The capsular-shaped film-coated tablets are brownish orange, unscored, and debossed “S51” on one side and blank on the other side. Tablets are provided in HDPE containers as follows: Bottles of 60 NDC 0527-1830-35 Bottles of 100 NDC 0527-1830-37 Store at 20º to 25ºC (68º to 77ºF); excursions permitted to 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]

More pills like OVAL S51

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

entacapone 200 MG Oral Tablet

FDA Reported Adverse Reactions [1] fatigue [2] off label use [3] drug ineffective [4] pain [5] toxicity to various agents [6] nausea [7] headache [8] arthralgia [9] dyspnoea [10] pyrexia

OVAL ORANGE S51

More pills like OVAL S51

FDA Reported Adverse Reactions
`[1] fatigue` `[2] off label use` `[3] drug ineffective` `[4] pain` `[5] toxicity to various agents` `[6] nausea` `[7] headache` `[8] arthralgia` `[9] dyspnoea` `[10] pyrexia`